Survival results from STAMPEDE, radiotherapy for prostate cancer
21 Oct 2018
Survival results from STAMPEDE, radiotherapy for prostate cancer
Bispecific T-cell engaging therapy for adult ALL
The promise of immunotherapy in head and neck, and prostate cancer
The 'My Health Avatar' app for iManageCancer
MyPathway study: a novel precision oncology multiple basket trial
Precision CAR T cell therapeutics
Editor's Choice for June 2018
ASCO 2018 conference round up
Phase II results of olaparib and abiraterone for mCRPC
Phase III results of PROSPECT study for metastatic, castration-resistant prostate cancer
Sunitinib with or without surgery for metastatic renal cell carcinoma
Comment: Kidney surgery may be unneeded in many intermediate-risk patients